Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634643 · ClinicalTrials.gov registry record
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
A clinical trial of NAFLD, sponsored by Yale University.
- Recruiting
- Registry status
- 260
- Enrollment target
- 1
- Study location
NCT04634643: Recruiting study of NAFLD, sponsored by Yale University.
NCT04634643 is a study of NAFLD that is actively recruiting participants, run by Yale University. The registered enrollment target is 260 participants, above the 155-participant average among 26 other NAFLD trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04634643, a study of NAFLD, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
The main aim of the study is to discover the mechanisms underlying the pathophysiology of NAFLD in obese youth.
Primary Outcome
lactate synthesis will be measured during an oral glucose tolerance test by measuring lactate. Synthetic rates will be measured by using a mathematical model.
Conditions Studied
Interventions
- OTHER Usual diet and physical activity
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2021-06-28 |
| Est. Completion | 2026-01-30 |
What NCT04634643 shows while recruiting
NCT04634643 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, above the 155-participant average among 26 other NAFLD trials with a reported enrollment target (68% higher).
The record links to 1 condition, with NAFLD appearing as the primary indexed condition, and to 1 intervention - of which Usual diet and physical activity is the first listed.
NCT04634643 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04634643 about?
NCT04634643 is a clinical study titled "Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)". The main aim of the study is to discover the mechanisms underlying the pathophysiology of NAFLD in obese youth.
What is the current status of trial NCT04634643?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2021-06-28. Estimated completion is 2026-01-30.
What conditions does trial NCT04634643 study?
This clinical trial studies the following conditions: NAFLD.
What interventions are being tested in trial NCT04634643?
The interventions under investigation include: Usual diet and physical activity (OTHER).
Who is sponsoring clinical trial NCT04634643?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04634643 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04634643's enrollment target sits among peer trials
260 4th of 26 higher than 23 of 26 other NAFLD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NAFLD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
RECRUITING · Phase 2
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
Digoxin In NASH (CODIN)
RECRUITING · Phase 2
-
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
RECRUITING · Phase 3
-
Bicalutamide Therapy in Young Women With NAFLD and PCOS
RECRUITING · Phase 1
-
Androgens and NAFLD Longitudinal Cohort Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI